Recent News
On August 18, 2026 Nutex Health opened the West Little Rock Emergency Hospital, its 28th facility nationwide, expanding 24/7 micro-hospital capacity in Arkansas. Institutional and insider flows appeared active in early August: multiple filings reported modest purchases and RSU conversions by directors and small institutional position changes in the first two weeks of August.
Technical Analysis
ADX/DI+: ADX at 34.42 signals a strong trend in place. DI+ shows a peak-and-reversal, which signals buyer momentum has rolled over and introduces bearish directional pressure; DI- is decreasing, which indicates selling pressure recently eased. Together, trend strength persists while directional bias shifts away from pure buyer domination, raising short-term downside risk relative to the current valuation.
MACD: MACD sits at 7.29 and trends higher with the MACD line above the signal line (MACD signal 5.08), constituting a bullish momentum confirmation that supports continuation of the advance unless the MACD peak reverses.
MRO: The Momentum/Regression Oscillator at 25.22 sits positive, which implies price currently trades above the oscillator’s target and introduces mean-reversion pressure that could push price lower toward fundamental anchors if momentum stalls.
RSI: RSI at 55.37 and rising indicates mild bullish momentum without overbought extremes, supporting the potential for additional upside while leaving room for pullbacks.
Price vs Moving Averages & Bands: Price closed at $185.84, above the 12- and 26-day EMAs and above 20-, 50-, and 200-day averages; that alignment favors bullish bias. Price remains inside the upper Bollinger envelope (upper 1x std dev $194.23), so volatility could expand to the upside but leaves room for a reversion to moving-average support (super trend lower $163.46) if buying pressure fades.
Volume & Volatility: Daily volume (~114,860) trades below recent 10/50/200-day averages, implying recent moves carried lighter participation; both 42-day and 52-week volatility sit near 6%, suggesting moderate realized volatility despite elevated beta (42-day beta 2.65, 52-week beta 2.13).
Fundamental Analysis
Profitability: Operating income $121,718,000 and EBIT $121,756,000 produce an EBIT margin of 57.77%, and an operating margin of 57.75%, both materially above the industry peer mean (EBIT margin industry peer mean 16.31% and industry peer high ~34.99%). Gross margin at 67.04% also sits above the industry peer mean 52.80%, supporting a premium margin profile driven by the hospital and PHM mix.
Liquidity & Cash: Cash and short-term investments total $205,208,000 with a current ratio near 5.00 and a quick ratio of 4.96, indicating a strong near-term liquidity cushion relative to typical peers. Operating cash flow $34,200,000 and free cash flow $31,660,000 produce a free cash flow yield of 3.10%, above the industry peer mean ~1.54%.
Leverage & Coverage: Total debt $347,336,000 yields debt-to-EBITDA about 2.73 and debt-to-equity 0.88; interest coverage ~26.07 provides ample coverage of interest expense and reduces refinancing strain risk in the current rate environment.
Growth & Returns: Total revenue $210,752,000 with reported revenue growth close to -2.65% (overall). Reported QoQ and YoY growth metrics in the file show large numeric moves; earnings growth on the period registers positive at ~63.42% but sequential and annual growth series vary by metric. Return on equity registers ~16.70% and return on invested capital ~23.08%, reflecting efficient capital deployment given current scale.
Earnings & Valuation Signals: Q2 reported EPS $9.38 versus consensus $4.95, a $4.43 beat and an ~89.5% surprise; the 8-K and related releases document the quarter’s results and commentary. Enterprise multiple stands near 9.16 and enterprise-value-to-revenue metrics imply valuation below many peers’ averages. The current valuation as determined by WMDST: under-valued.
MOST-RECENT QUARTERLY REPORT
| REPORT PERIOD ENDING: | 2026-06-30 |
| REPORT DATE: | 2026-08-06 |
| NEXT REPORT DATE: | 2026-11-05 |
| CASH FLOW | Begin Period Cash Flow | $ 207.3 M |
| Operating Cash Flow | $ 34.2 M | |
| Capital Expenditures | $ -2.54 M | |
| Change In Working Capital | $ -20.72 M | |
| Dividends Paid | $ -13.26 M | |
| Cash Flow Delta | $ -239.00 K | |
| End Period Cash Flow | $ 207.1 M | |
| INCOME STATEMENT | REVENUE | |
| Total Revenue | $ 210.8 M | |
| Forward Revenue | $ 27.8 M | |
| COSTS | ||
| Cost Of Revenue | $ 69.5 M | |
| Depreciation | $ 5.3 M | |
| Depreciation and Amortization | $ 5.3 M | |
| Research and Development | — | |
| Total Operating Expenses | $ 89.0 M | |
| PROFITABILITY | ||
| Gross Profit | $ 141.3 M | |
| EBITDA | $ 127.1 M | |
| EBIT | $ 121.8 M | |
| Operating Income | $ 121.7 M | |
| Interest Income | — | |
| Interest Expense | $ 4.7 M | |
| Net Interest Income | $ -4.67 M | |
| Income Before Tax | $ 117.1 M | |
| Tax Provision | $ 20.8 M | |
| Tax Rate | 17.738 % | |
| Net Income | $ 65.8 M | |
| Net Income From Continuing Operations | $ 96.3 M | |
| EARNINGS | ||
| EPS Estimate | $ 4.95 | |
| EPS Actual | $ 9.38 | |
| EPS Difference | $ 4.43 | |
| EPS Surprise | 89.495 % | |
| Forward EPS | $ 5.08 | |
| BALANCE SHEET | ASSETS | |
| Total Assets | $ 964.6 M | |
| Intangible Assets | $ 34.5 M | |
| Net Tangible Assets | $ 359.8 M | |
| Total Current Assets | $ 585.6 M | |
| Cash and Short-Term Investments | $ 205.2 M | |
| Cash | $ 205.2 M | |
| Net Receivables | $ 356.7 M | |
| Inventory | $ 4.2 M | |
| Long-Term Investments | $ 3.6 M | |
| LIABILITIES | ||
| Accounts Payable | $ 10.0 M | |
| Short-Term Debt | $ 8.6 M | |
| Total Current Liabilities | $ 117.2 M | |
| Net Debt | — | |
| Total Debt | $ 347.3 M | |
| Total Liabilities | $ 457.3 M | |
| EQUITY | ||
| Total Equity | $ 394.3 M | |
| Retained Earnings | $ -173.54 M | |
| VALUATION & PER-SHARE METRICS | EQUITY & PER-SHARE METRICS | |
| Book Value Per-Share | $ 57.62 | |
| Shares Outstanding | 6.844 M | |
| Revenue Per-Share | $ 30.79 | |
| VALUATION | Market Capitalization | $ 1.0 B |
| Enterprise Value | $ 1.2 B | |
| Enterprise Multiple | 9.161 | |
| Enterprise Multiple QoQ | -12.713 % | |
| Enterprise Multiple YoY | -67.148 % | |
| Enterprise Multiple IPRWA | high: 82.974 mean: 35.249 median: 34.394 low: 14.996 NUTX: 9.161 |
|
| EV/R | 5.524 | |
| CAPITAL STRUCTURE | ||
| Asset To Equity | 2.446 | |
| Asset To Liability | 2.109 | |
| Debt To Capital | 0.468 | |
| Debt To Assets | 0.36 | |
| Debt To Assets QoQ | -1.256 % | |
| Debt To Assets YoY | -12.285 % | |
| Debt To Assets IPRWA | high: 0.838 median: 0.815 mean: 0.661 NUTX: 0.36 low: 0.02 |
|
| Debt To Equity | 0.881 | |
| Debt To Equity QoQ | -12.619 % | |
| Debt To Equity YoY | -39.978 % | |
| Debt To Equity IPRWA | high: 3.407 NUTX: 0.881 mean: -5.22 median: -7.762 low: -17.523 |
|
| PRICE-BASED VALUATION | ||
| Price To Book (P/B) | 2.592 | |
| Price To Book QoQ | 16.779 % | |
| Price To Book YoY | -15.075 % | |
| Price To Book IPRWA | high: 7.269 NUTX: 2.592 mean: -7.613 median: -13.296 low: -17.699 |
|
| Price To Earnings (P/E) | 15.92 | |
| Price To Earnings QoQ | -17.345 % | |
| Price To Earnings YoY | 13.484 % | |
| Price To Earnings IPRWA | high: 102.685 mean: 54.569 median: 53.381 NUTX: 15.92 low: -16.66 |
|
| PE/G Ratio | 0.251 | |
| Price To Sales (P/S) | 4.849 | |
| Price To Sales QoQ | 36.591 % | |
| Price To Sales YoY | 64.793 % | |
| Price To Sales IPRWA | high: 15.055 NUTX: 4.849 mean: 4.675 median: 4.365 low: 0.158 |
|
| FORWARD MULTIPLES | ||
| Forward P/E | 25.813 | |
| Forward PE/G | 0.407 | |
| Forward P/S | 36.717 | |
| EFFICIENCY | OPERATIONAL | |
| Operating Leverage | -18.831 | |
| ASSET & SALES | ||
| Asset Turnover Ratio | 0.219 | |
| Asset Turnover Ratio QoQ | -4.982 % | |
| Asset Turnover Ratio YoY | -27.958 % | |
| Asset Turnover Ratio IPRWA | high: 0.324 median: 0.324 mean: 0.277 NUTX: 0.219 low: 0.098 |
|
| Receivables Turnover | 0.6 | |
| Receivables Turnover Ratio QoQ | -6.983 % | |
| Receivables Turnover Ratio YoY | -19.559 % | |
| Receivables Turnover Ratio IPRWA | high: 2.963 mean: 1.863 median: 1.714 low: 1.319 NUTX: 0.6 |
|
| Inventory Turnover | 15.637 | |
| Inventory Turnover Ratio QoQ | -52.716 % | |
| Inventory Turnover Ratio YoY | -64.586 % | |
| Inventory Turnover Ratio IPRWA | high: 27.355 NUTX: 15.637 mean: 7.159 median: 6.686 low: 1.469 |
|
| Days Sales Outstanding (DSO) | 152.103 | |
| CASH CYCLE | ||
| Cash Conversion Cycle Days (CCC) | 133.289 | |
| Cash Conversion Cycle Days QoQ | 30.932 % | |
| Cash Conversion Cycle Days YoY | 36.207 % | |
| Cash Conversion Cycle Days IPRWA | NUTX: 133.289 high: 41.543 median: 27.773 mean: -31.078 low: -410.097 |
|
| CAPITAL DEPLOYMENT | ||
| Cash Conversion Ratio | 0.45 | |
| CapEx To Revenue | -0.012 | |
| CapEx To Depreciation | -0.478 | |
| CAPITAL, LIQUIDITY & COVERAGE | CAPITAL STRUCTURE | |
| Total Capital | $ 425.4 M | |
| Net Invested Capital | $ 434.0 M | |
| Invested Capital | $ 434.0 M | |
| Net Tangible Assets | $ 359.8 M | |
| Net Working Capital | $ 468.4 M | |
| LIQUIDITY | ||
| Cash Ratio | 1.751 | |
| Current Ratio | 4.996 | |
| Current Ratio QoQ | 58.971 % | |
| Current Ratio YoY | 105.829 % | |
| Current Ratio IPRWA | NUTX: 4.996 high: 1.862 mean: 1.141 low: 0.993 median: 0.993 |
|
| Quick Ratio | 4.96 | |
| Quick Ratio QoQ | 59.113 % | |
| Quick Ratio YoY | 105.338 % | |
| Quick Ratio IPRWA | NUTX: 4.96 high: 2.552 mean: 1.102 low: 0.897 median: 0.897 |
|
| COVERAGE & LEVERAGE | ||
| Debt To EBITDA | 2.733 | |
| Cost Of Debt | 1.103 % | |
| Interest Coverage Ratio | 26.066 | |
| Interest Coverage Ratio QoQ | 50.221 % | |
| Interest Coverage Ratio YoY | 403.247 % | |
| Interest Coverage Ratio IPRWA | high: 70.154 NUTX: 26.066 mean: 10.073 median: 5.164 low: 1.576 |
|
| Operating Cash Flow Ratio | 0.174 | |
| TIMING / LIQUIDITY | ||
| Days Payables Outstanding (DPO) | 22.064 | |
| DIVIDENDS | ||
| Dividend Coverage Ratio | 4.964 | |
| Dividend Payout Ratio | 0.201 | |
| Dividend Rate | $ 1.94 | |
| Dividend Yield | 0.013 | |
| PERFORMANCE | GROWTH | |
| Asset Growth Rate | 0.764 % | |
| Revenue Growth | -2.648 % | |
| Revenue Growth QoQ | -106.198 % | |
| Revenue Growth YoY | -117.419 % | |
| Revenue Growth IPRWA | high: 14.758 % median: 5.866 % mean: 5.166 % NUTX: -2.648 % low: -4.722 % |
|
| Earnings Growth | 63.415 % | |
| Earnings Growth QoQ | -75.065 % | |
| Earnings Growth YoY | -81.124 % | |
| Earnings Growth IPRWA | NUTX: 63.415 % high: 44.444 % mean: 11.398 % median: 6.154 % low: -3.125 % |
|
| MARGINS | ||
| Gross Margin | 67.036 % | |
| Gross Margin QoQ | 58.208 % | |
| Gross Margin YoY | 30.925 % | |
| Gross Margin IPRWA | high: 96.512 % NUTX: 67.036 % mean: 52.802 % median: 44.755 % low: 14.068 % |
|
| EBIT Margin | 57.772 % | |
| EBIT Margin QoQ | 53.944 % | |
| EBIT Margin YoY | 379.277 % | |
| EBIT Margin IPRWA | NUTX: 57.772 % high: 34.992 % mean: 16.31 % median: 15.289 % low: 6.102 % |
|
| Return On Sales (ROS) | 57.754 % | |
| Return On Sales QoQ | 53.855 % | |
| Return On Sales YoY | 318.386 % | |
| Return On Sales IPRWA | NUTX: 57.754 % high: 33.23 % mean: 15.905 % median: 15.161 % low: 5.77 % |
|
| CASH FLOW | ||
| Free Cash Flow (FCF) | $ 31.7 M | |
| Free Cash Flow Yield | 3.098 % | |
| Free Cash Flow Yield QoQ | -67.963 % | |
| Free Cash Flow Yield YoY | -16.089 % | |
| Free Cash Flow Yield IPRWA | high: 4.809 % NUTX: 3.098 % mean: 1.539 % median: 1.25 % low: 0.588 % |
|
| Free Cash Growth | -57.399 % | |
| Free Cash Growth QoQ | -841.877 % | |
| Free Cash Growth YoY | 19.766 % | |
| Free Cash Growth IPRWA | high: 84.175 % median: 23.352 % mean: -1.663 % NUTX: -57.399 % low: -351.306 % |
|
| Free Cash To Net Income | 0.481 | |
| Cash Flow Margin | 9.688 % | |
| Cash Flow To Earnings | 0.31 | |
| VALUE & RETURNS | ||
| Economic Value Added | $ 0.03 | |
| Return On Assets (ROA) | 6.852 % | |
| Return On Assets QoQ | 37.287 % | |
| Return On Assets YoY | -410.326 % | |
| Return On Assets IPRWA | NUTX: 6.852 % high: 2.725 % median: 2.725 % mean: 2.39 % low: 0.197 % |
|
| Return On Capital Employed (ROCE) | 14.368 % | |
| Return On Equity (ROE) | 0.167 | |
| Return On Equity QoQ | 23.533 % | |
| Return On Equity YoY | -321.959 % | |
| Return On Equity IPRWA | high: 0.177 NUTX: 0.167 mean: -0.141 median: -0.256 low: -0.347 |
|
| DuPont ROE | 17.78 % | |
| Return On Invested Capital (ROIC) | 23.077 % | |
| Return On Invested Capital QoQ | 34.239 % | |
| Return On Invested Capital YoY | 225.992 % | |
| Return On Invested Capital IPRWA | NUTX: 23.077 % high: 6.725 % median: 5.558 % mean: 5.04 % low: 0.822 % |
|